Chemoinformaics analysis of Cyclopentanone, 3-[3,5-decadienyl]-, (E,E)-
Molecular Weight | 220.356 | nRot | 7 |
Heavy Atom Molecular Weight | 196.164 | nRig | 8 |
Exact Molecular Weight | 220.183 | nRing | 1 |
Solubility: LogS | -2.637 | nHRing | 0 |
Solubility: LogP | 2.865 | No. of Aliphatic Rings | 1 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
Atoms Count | 40 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 0 |
nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 1 |
No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 15 | No. of Saturated Rings | 1 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
nHA | 1 | APOL | 41.855 |
nHD | 0 | BPOL | 24.945 |
QED | 0.458 |
Synth | 3.249 |
Natural Product Likeliness | 2.011 |
NR-PPAR-gamma | 0.278 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.852 |
Pgp-sub | 0.001 |
HIA | 0.006 |
CACO-2 | -4.652 |
MDCK | 0.000037 |
BBB | 0.905 |
PPB | 0.899925 |
VDSS | 0.787 |
FU | 0.0472175 |
CYP1A2-inh | 0.682 |
CYP1A2-sub | 0.917 |
CYP2c19-inh | 0.667 |
CYP2c19-sub | 0.695 |
CYP2c9-inh | 0.456 |
CYP2c9-sub | 0.98 |
CYP2d6-inh | 0.521 |
CYP2d6-sub | 0.934 |
CYP3a4-inh | 0.637 |
CYP3a4-sub | 0.188 |
CL | 4.881 |
T12 | 0.689 |
hERG | 0.206 |
Ames | 0.07 |
ROA | 0.018 |
SkinSen | 0.929 |
Carcinogencity | 0.4 |
EI | 0.977 |
Respiratory | 0.903 |
NR-Aromatase | 0.01 |
Antiviral | Yes |
Prediction | 0.765925 |